Covalon Technologies Ltd.

Good morning ladies and gentlemen and welcome to Kovalon's Q2 fiscal 2022 conference call and webcast. My name is Michelle and I will be your conference operator today. As a reminder, today's conference is being recorded. All lines have been placed on mute to prevent any background noise and after the speaker's remarks, there will be a question and answer session. If you would like to ask a question during that time, press star then the number one on your telephone keypad if you would like to withdraw your question please press the star followed by the number two alternatively you can submit typed questions via the webcast at this time I would like to turn the conference over to mr. Brian peddler president and chief executive officer and mr. Jason Gorel interim chief financial officer and Please go ahead, Mr. Pedler and Mr. Gorel.

Thanks, Michelle. Good morning, fellow investors. Thank you for joining us in this call. Emily Hill from Covalon is helping to coordinate the conference call and webcast, and she will now provide us with some instructions.

Thanks, Brian. Good morning, everyone. My name is Emily Hill. I'm the Executive Assistant to Covalon's Chief Executive Officer. I'd like to thank everyone for taking the time this morning to attend our conference call and webcast. We will be discussing the financial statements, MD&A, and press release related to Covalent's second quarter, ended March 31, 2022. There will be an opportunity for you to ask questions at the end of our call. So before we begin the discussion, I would like to remind participants that this call and webcast are covered by Covalent's Safe Harbor Statement. Certain statements included on this conference call may be considered forward-looking. Such statements involve known and unknown risks. uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from those implied by our statements, and, therefore, these statements should not be taken as guarantees of future performance or results. All forward-looking statements are based on management's current beliefs, assumptions, and information currently available to us and related to anticipated financial performance, business prospects, partnership opportunities, strategies, regulatory developments, market acceptance, and future commitments, among other things. Participants on this conference call are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this call. Due to risks and uncertainties, including those identified by COGLON in our public security filings, actual events may differ materially from current expectations. COGLON disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. In the management's discussion and analysis, press release, and in this call, Covalent has provided non-IFRS measures that are meant to provide further understanding of our results by helping to highlight trends and assist in comparing different periods. The adjusted gross margin and adjusted EBITDA are terms that do not have any standardized meaning and may not be comparable to other companies. These measures are not meant to replace the similar IFRS measures, and any adjusting items may recur in the future. I will now turn the call back over to you, Brian.